Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | branched chain amino-acid transaminase 2, mitochondrial | Starlite/ChEMBL | References |
Homo sapiens | branched chain amino-acid transaminase 1, cytosolic | Starlite/ChEMBL | References |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AUC (ADMET) | = 306 ug.hr/ml | AUC (0 to t) in C57-B6 mouse at 1 mg/kg, iv and 5 mg/kg, po | ChEMBL. | 26090771 |
IC50 (binding) | = 6.6 | Inhibition of BCATc (unknown origin) | ChEMBL. | 26090771 |
IC50 (binding) | = 6.8 | Inhibition of BCATm in differentiated primary human adipocytes assessed as remaining leucine level by reversed phase HPLC analysis | ChEMBL. | 26090771 |
IC50 (binding) | = 7.3 | Inhibition of human cloned BCATm expressed in Escherichia coli BL21 DE3 assessed as L-glutamate production from alpha-ketoglutarate after 10 mins by fluorescent assay | ChEMBL. | 26090771 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.